Intelligent Bio Solutions (INBS) Operating Expenses (2019 - 2025)

Intelligent Bio Solutions has reported Operating Expenses for 7 years, with the latest figure at $582466.0 in Q2 2025.

• For the quarter ending Q2 2025, Operating Expenses fell 22.35% year-over-year to $582466.0; the trailing twelve-month figure through Jun 2025 stood at $9.5 million (up 3.25% YoY), and the FY2025 full-year result was $2.4 million, up 42.78% from the prior year.
• Operating Expenses for Q2 2025 stood at $582466.0, down from $3.1 million in the prior quarter.
• The five-year high for Operating Expenses was $6.7 million in Q1 2023, with the low at $582466.0 in Q2 2025.
• Average Operating Expenses over 5 years is $2.6 million, with a median of $2.6 million recorded in 2022.
• Year-over-year, Operating Expenses jumped 11533.16% in 2021 and plunged 73.13% in 2024.
• Tracing INBS's Operating Expenses over 5 years: stood at $3.6 million in 2021, then fell by 27.43% to $2.6 million in 2022, then declined by 11.37% to $2.3 million in 2023, then rose by 11.84% to $2.6 million in 2024, then plunged by 77.78% to $582466.0 in 2025.
• The last three Operating Expenses figures came in at $582466.0 (Q2 2025), $3.1 million (Q1 2025), and $2.6 million (Q4 2024), per Business Quant data.

Peer Comparison